Sabine Fuertinger

Title: Sabine Fuertinger: Innovator in Pharmaceutical Formulations

Introduction

Sabine Fuertinger is a notable inventor based in Kundl, Austria. She has made significant contributions to the field of pharmaceutical formulations, particularly in the development of stable aqueous solutions for biopharmaceuticals. With a total of 2 patents to her name, her work has the potential to impact the efficacy and stability of important therapeutic proteins.

Latest Patents

Her latest patents include a "Stable aqueous formulation for growth hormone," which relates to a pharmaceutically acceptable aqueous formulation comprising at least a neutral salt and a biopharmaceutical protein. The concentration ratio between the biopharmaceutical protein and the neutral salt is crucial, falling within the range of ≥0.7 and ≤5. Another significant patent is for "Stable pharmaceutical liquid formulations of the fusion protein TNFR:Fc." This invention demonstrates that the physical stability of TNFR:Fc can be significantly improved by utilizing a citrate buffer system and lysine as a stabilizer.

Career Highlights

Sabine Fuertinger is currently employed at Sandoz AG, a global leader in generic pharmaceuticals and biosimilars. Her work at Sandoz has allowed her to focus on innovative solutions that enhance the stability and effectiveness of pharmaceutical products.

Collaborations

Throughout her career, Sabine has collaborated with talented colleagues, including Britta Deutel and Thomas Lauber. These collaborations have fostered an environment of innovation and have contributed to the successful development of her patented formulations.

Conclusion

Sabine Fuertinger's contributions to pharmaceutical formulations exemplify the importance of innovation in the healthcare sector. Her patents not only enhance the stability of critical biopharmaceuticals but also pave the way for future advancements in the field.